102 related articles for article (PubMed ID: 1461933)
1. Cancer destruction in vivo through disrupted energy metabolism. Part III. Spontaneous drug resistance, selectivity of antineoplastic action, and strategies for intensifying tumor injury.
Jones GR
Physiol Chem Phys Med NMR; 1992; 24(3):195-212. PubMed ID: 1461933
[TBL] [Abstract][Full Text] [Related]
2. Cancer destruction in vivo through disrupted energy metabolism. Part II. Lipid peroxidation and cell death; drug resistance as a consequence of reversible cellular injury.
Jones GR
Physiol Chem Phys Med NMR; 1992; 24(3):181-94. PubMed ID: 1461932
[TBL] [Abstract][Full Text] [Related]
3. Cancer destruction in vivo through disrupted energy metabolism. Part I. The endogenous mechanism of self-destruction within the malignant cell, and the roles of endotoxin, certain hormones and drugs, and active oxygen in causing cellular injury and death.
Jones GR
Physiol Chem Phys Med NMR; 1992; 24(3):169-79. PubMed ID: 1461931
[TBL] [Abstract][Full Text] [Related]
4. Tumor cell metabolism: cancer's Achilles' heel.
Kroemer G; Pouyssegur J
Cancer Cell; 2008 Jun; 13(6):472-82. PubMed ID: 18538731
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic strategies by modulating oxygen stress in cancer and inflammation.
Fang J; Seki T; Maeda H
Adv Drug Deliv Rev; 2009 Apr; 61(4):290-302. PubMed ID: 19249331
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced interference with energy metabolism in the S180 sarcoma: a new principle in the production of selective tumor injury.
Jones GR; Ellis R; Frohn MJ
Oncodev Biol Med; 1981; 2(3):155-64. PubMed ID: 7301609
[TBL] [Abstract][Full Text] [Related]
7. Targeting of cancer energy metabolism.
Rodríguez-Enríquez S; Marín-Hernández A; Gallardo-Pérez JC; Carreño-Fuentes L; Moreno-Sánchez R
Mol Nutr Food Res; 2009 Jan; 53(1):29-48. PubMed ID: 19123180
[TBL] [Abstract][Full Text] [Related]
8. Energy balance, physical activity, and cancer risk.
Fair AM; Montgomery K
Methods Mol Biol; 2009; 472():57-88. PubMed ID: 19107429
[TBL] [Abstract][Full Text] [Related]
9. [Resistance to antineoplastic treatments: mechanisms, clinical value].
Bonnal C; Calvo F
C R Seances Soc Biol Fil; 1996; 190(4):455-66. PubMed ID: 8952896
[TBL] [Abstract][Full Text] [Related]
10. Expression of gamma-glutamyltransferase in cancer cells and its significance in drug resistance.
Pompella A; De Tata V; Paolicchi A; Zunino F
Biochem Pharmacol; 2006 Jan; 71(3):231-8. PubMed ID: 16303117
[TBL] [Abstract][Full Text] [Related]
11. Energy metabolism of human LoVo colon carcinoma cells: correlation to drug resistance and influence of lonidamine.
Fanciulli M; Bruno T; Giovannelli A; Gentile FP; Di Padova M; Rubiu O; Floridi A
Clin Cancer Res; 2000 Apr; 6(4):1590-7. PubMed ID: 10778993
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
13. Cancer Drug Development: New Targets for Cancer Treatment.
Curt GA
Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
[TBL] [Abstract][Full Text] [Related]
14. Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models.
Peer D; Dekel Y; Melikhov D; Margalit R
Cancer Res; 2004 Oct; 64(20):7562-9. PubMed ID: 15492283
[TBL] [Abstract][Full Text] [Related]
15. Antineoplastic drug resistance in brain tumors.
Phillips PC
Neurol Clin; 1991 May; 9(2):383-404. PubMed ID: 1682794
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of action and resistance of antineoplastic agents].
Tanaka N
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2245-51. PubMed ID: 6195971
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tumor growth by replacing glutathione with N-acetyl-L-cysteine.
Yildiz D
Med Hypotheses; 2004; 63(1):80-2. PubMed ID: 15193353
[TBL] [Abstract][Full Text] [Related]
18. Novel function of the thyroid hormone analog tetraiodothyroacetic acid: a cancer chemosensitizing and anti-cancer agent.
Rebbaa A; Chu F; Davis FB; Davis PJ; Mousa SA
Angiogenesis; 2008; 11(3):269-76. PubMed ID: 18386142
[TBL] [Abstract][Full Text] [Related]
19. In vitro assays of chemotherapeutic sensitivity.
Carney DN; Winkler CF
Important Adv Oncol; 1985; ():78-103. PubMed ID: 3916747
[TBL] [Abstract][Full Text] [Related]
20. Drug resistance mechanisms in cancer cells: a proteomics perspective.
Verrills NM; Kavallaris M
Curr Opin Mol Ther; 2003 Jun; 5(3):258-65. PubMed ID: 12870435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
